| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |